FAM3基因家族在肿瘤中的作用

doi:10.3760/cma.j.cn371439-20200311-00087

国际肿瘤学杂志 ›› 2020, Vol. 47 ›› Issue (10): 611-614.doi: 10.3760/cma.j.cn371439-20200311-00087

FAM3基因家族在肿瘤中的作用

廖成成¹, 安家兴², 谭张雪¹, 王倩³(), 刘建国^1,³()

¹遵义医科大学口腔医学院 563006
²遵义医科大学附属医院消化内科 563000
³贵州省普通高等学校口腔疾病研究特色重点实验室,遵义 563006

收稿日期:2020-03-11 修回日期:2020-04-27 出版日期:2020-10-08 发布日期:2020-11-20
通讯作者: 王倩,刘建国 E-mail:qianwang07@126.com;jgl_zmu@126.com
基金资助:
贵州省普通高等学校科技拔尖人才支持计划(黔教合KY字)(2016-080)

Role of FAM3 gene family in tumor

Liao Chengcheng¹, An Jiaxing², Tan Zhangxue¹, Wang Qian³(), Liu Jianguo^1,³()

¹School of Stomatology, Zunyi Medical University, Zunyi 563006, China
²Department of Gastroenterology, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China
³Special Key Laboratory of Oral Disease Research, Higher Education Institution in Guizhou Province, Zunyi Medical University, Zunyi 563006, China

Received:2020-03-11 Revised:2020-04-27 Online:2020-10-08 Published:2020-11-20
Contact: Wang Qian,Liu Jianguo E-mail:qianwang07@126.com;jgl_zmu@126.com
Supported by:
Scientific Talent Fund of Guizhou College(2016-080)

摘要/Abstract

摘要：

序列相似家族3(FAM3)基因家族与人类肿瘤关系密切,其在糖脂代谢及血管再生等方面具有重要作用,与食管鳞状细胞癌、胃癌、结肠癌、胰腺癌、口腔鳞状细胞癌和乳腺癌的发生发展相关。分析FAM3基因家族在糖脂代谢及肿瘤中的作用对于认识人类肿瘤的发生发展具有重要意义。

关键词: 肿瘤, 糖脂代谢, FAM3基因家族

Abstract:

Family with sequence similarity 3 (FAM3) gene family is closely related to human tumors, and plays an important role in glucose and lipid metabolism and angiogenesis, and it is related to the occurrence and development of esophageal squamous cell carcinoma, gastric cancer, colon cancer, pancreatic cancer, oral squamous cell carcinoma and breast cancer. Analysis of the role of the FAM3 gene family in glycolipid metabolism and tumors may be of great significance for understanding the occurrence and development of human tumors.

Key words: Neoplasms, Glycolipid metabolism, Family with sequence similarity 3

廖成成, 安家兴, 谭张雪, 王倩, 刘建国. FAM3基因家族在肿瘤中的作用[J]. 国际肿瘤学杂志, 2020, 47(10): 611-614.

Liao Chengcheng, An Jiaxing, Tan Zhangxue, Wang Qian, Liu Jianguo. Role of FAM3 gene family in tumor[J]. Journal of International Oncology, 2020, 47(10): 611-614.

参考文献 31

[1]	Zhang X, Yang W, Wang J, et al. FAM3 gene family: a promising therapeutical target for NAFLD and type 2 diabetes[J]. Metabolism, 2018,81:71-82. DOI: 10.1016/j.metabol.2017.12.001. pmid: 29221790
[2]	Tanasova M, Begoyan VV, Weselinski LJ. Targeting sugar uptake and metabolism for cancer identification and therapy: an overview[J]. Curr Top Med Chem, 2018,18(6):467-483. DOI: 10.2174/1568026618666180523110837. pmid: 29788891
[3]	Cao Y. Adipocyte and lipid metabolism in cancer drug resistance[J]. J Clin Invest, 2019,129(8):3006-3017. DOI: 10.1172/JCI127201. pmid: 31264969
[4]	Wang H, Yu F, Zhang Z, et al. Effects of circulating member B of the family with sequence similarity 3 on the risk of developing metabolic syndrome and its components:a 5-year prospective study[J]. J Diabetes Investig, 2018,9(4):782-788. DOI: 10.1111/jdi.12780. pmid: 29178453
[5]	Xiang R, Chen J, Li S, et al. VSMC-specific deletion of FAM3A attenuated angⅡ-promoted hypertension and cardiovascular hypertrophy[J]. Circ Res, 2020, In press. DOI: 10.1161/CIRCRESAHA.119.315558. doi: 10.1161/CIRCRESAHA.120.317045 pmid: 33107387
[6]	Xu W, Liang M, Zhang Y, et al. Endothelial FAM3A positively regulates post-ischaemic angiogenesis[J]. EBioMedicine, 2019,43:32-42. DOI: 10.1016/j.ebiom.2019.03.038. pmid: 31000420
[7]	Chaudhury A, Hussey GS, Ray PS, et al. TGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translatio-nal induction of Dab2 and ILEI[J]. Nat Cell Biol, 2010,12(3):286-293. DOI: 10.1038/ncb2029. doi: 10.1038/ncb2029 pmid: 20154680
[8]	Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]. Gastroenterology, 2018,154(2):360-373. DOI: 10.1053/j.gastro.2017.08.023. pmid: 28823862
[9]	Zhu YH, Zhang B, Li M, et al. Prognostic significance of FAM3C in esophageal squamous cell carcinoma[J]. Diagn Pathol, 2015,10:192. DOI: 10.1186/s13000-015-0424-8. doi: 10.1186/s13000-015-0424-8
[10]	Jin LL, Zhang SJ, Lu GX, et al. miR-574-3p inhibits proliferation and invasion in esophageal cancer by targeting FAM3C and MAPK1[J]. Kaohsiung J Med Sci, 2020,36(5):318-327. DOI: 10.1002/kjm2.12176.
[11]	He SL, Wang WP, Yang YS, et al. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition[J]. J Cell Mol Med, 2019,23(2):1375-1385. DOI: 10.1111/jcmm14040.
[12]	Song WM, Lin X, Liao X, et al. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer[J]. Int J Cancer, 2020,146(5):1268-1280. DOI: 10.1002/ijc.32643. doi: 10.1002/ijc.32643 pmid: 31463974
[13]	李海军, 王孟薇, 吴本俨, 等. FAM3B基因cDNA克隆及其在胃癌细胞系BGC-823的表达[J]. 中国药物与临床, 2007,7(12):896-898. DOI: 10.3969/j.issn.1671-2560.2007.12.002.
[14]	Shi M, Duan G, Nie S, et al. Elevated FAM3C promotes cell epithelial-mesenchymal transition and cell migration in gastric cancer[J]. Onco Targets Ther, 2018,11:8491-8505. DOI: 10.2147/OTT.S178455. doi: 10.2147/OTT.S178455 pmid: 30584315
[15]	Ahmed M. Colon cancer: a clinician's perspective in 2019[J]. Gastroenterology Res, 2020,13(1):1-10. DOI: 10.14740/gr1239. pmid: 32095167
[16]	Li Z, Mou H, Wang T, et al. A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression[J]. Cancer Lett, 2013,328(2):278-284. DOI: 10.1016/j.canlet.2012.09.026. doi: 10.1016/j.canlet.2012.09.026 pmid: 23059759
[17]	万晓晨, 马小红, 程璐, 等. FAM3C蛋白与结肠癌临床病理相关性[J]. 肿瘤学杂志, 2017,23(5):413-416. DOI: 10.11735/j.issn.1671-170X.2017.05.B011.
[18]	Gao ZH, Lu C, Wang ZN, et al. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer[J]. Histopathology, 2014,65(4):527-538. DOI: 10.1111/his.12435. pmid: 24738665
[19]	Solmi R, De Sanctis P, Zucchini C, et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR[J]. INT J Oncol, 2004,25(4):1049-1056. pmid: 15375555
[20]	Llach J, Carballal S, Moreira L. Familial pancreatic cancer: current perspectives[J]. Cancer Manag Res, 2020,12:743-758. DOI: 10.2147/CMAR.S172421. doi: 10.2147/CMAR.S172421 pmid: 32099470
[21]	Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach[J]. Mol Cell Proteomics, 2006,5(1):157-171. DOI: 10.1074/mcp.M500178-MCP200.
[22]	Souza JJS, Machado MCC, Fortes MAHZ, et al. Cytokine-like FAM3D gene is associated to diabetes mellitus in pancreatic adenocarcinoma[J]. Pancreas, 2006,33(4):498. DOI: 10.1097/00006676-200611000-00208.
[23]	Holt JD, Gerayli F. Prostate cancer screening[J]. Prim Care, 2019,46(2):257-263. DOI: 10.1016/j.pop.2019.02.007.
[24]	Maciel-Silva P, Caldeira I, de Assis Santos I, et al. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes[J]. BMC Cancer, 2018,18(1):90. DOI: 10.1186/s12885-017-3950-9. pmid: 29357840
[25]	Sun Y, Jia X, Gao Q, et al. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI)[J]. IUBMB Life, 2017,69(1):16-21. DOI: 10.1002/iub.1585.
[26]	La Rosa GRM, Gattuso G, Pedullà E, et al. Association of oral dysbiosis with oral cancer development[J]. Oncol Lett, 2020,19(4):3045-3058. DOI: 10.3892/ol.2020.11441. doi: 10.3892/ol.2020.11441 pmid: 32211076
[27]	Wu CC, Xiao Y, Li H, et al. Overexpression of FAM3C is associa-ted with poor prognosis in oral squamous cell carcinoma[J]. Pathol Res Pract, 2019,215(4):772-778. DOI: 10.1016/j.prp.2019.01.019.
[28]	迟毓婧, 李玫, 禹祎萌, 等. FAM3C通过激活Akt促进口腔鳞癌细胞活力[J]. 中国病理生理杂志, 2019,35(3):424-429. DOI: 10.3969/j.issn.1000-4718.2019.03.007.
[29]	De Cicco P, Catani MV, Gasperi V, et al. Nutrition and breast cancer: a literature review on prevention, treatment and recurrence[J]. Nutrients, 2019,11(7):1514. DOI: 10.3390/nu11071514.
[30]	Woosley AN, Dalton AC, Hussey GS, et al. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis[J]. Oncogene, 2019,38(20):3794-3811. DOI: 10.1038/s41388-019-0703-z. doi: 10.1038/s41388-019-0703-z pmid: 30692635
[31]	Yang W, Feng B, Meng Y, et al. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1[J]. J Cell Mol Med, 2019,23(5):3464-3475. DOI: 10.1111/jcmm.14243. doi: 10.1111/jcmm.14243 pmid: 30887707

FAM3基因家族在肿瘤中的作用

Role of FAM3 gene family in tumor

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 31

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲. 血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊. 局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华. Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青. 血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺. PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云. 新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚. EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵. 抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六. 基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六. 肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东. ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅. 基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳. 炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝. 癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志. 宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.